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Abstract A new approach for site-directed placement of nitro-
xide spin labels in chemically synthesized peptides and proteins
is described. The scheme takes advantage of a novel diamino-
propionic acid sca¡old to independently control backbone and
side chain elongation. The result is a spin-labeled side chain,
referred to as Dap-SL, in which an amide bond forms a linker
between the nitroxide and the peptide backbone. The method
was demonstrated in a series of helical peptides. Circular di-
chroism and nuclear magnetic resonance showed that Dap-SL
introduces only a minor perturbation in the helical structure.
The electron paramagnetic resonance spectrum of the singly
labeled species allowed for determination of the spin label rota-
tional correlation time and suggests that the Dap-SL side chain
is more £exible than the modi¢ed Cys side chain frequently used
in site-directed spin label studies. Spectra of the doubly labeled
peptides indicate a mixture of 310-helix and K-helix, which par-
allels ¢ndings from previous studies. The scheme demonstrated
here o¡ers a fundamentally new approach for introducing spin
labels into proteins and promises to signi¢cantly extend biophys-
ical investigations of large proteins and receptors. In addition,
the technique is readily modi¢ed for incorporation of any bio-
physical probe.
* 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Nitroxide spin label electron paramagnetic resonance (EPR)
is among the leading biophysical techniques for determining
structure and structural mobility in proteins [1,2]. To date,
there have been two fundamental approaches for attaching
nitroxides in a site-speci¢c fashion. The ¢rst, and by far
most common, uses microbial expression to produce a mutant
protein containing a non-native Cys at a chosen location.
Treatment with a thiol-speci¢c reagent, such as methanethio-
sulfonate spin label (MTSSL), then yields a side chain bearing
the nitroxide [3]. This approach, often referred to as site-di-
rected spin labeling (SDSL), has been remarkably successful
for studying membrane proteins (e.g. [4,5]), and large oligo-
meric structures such as that formed in the SNARE complex
[6] and by K-crystallin [7].
Another approach involves solid-phase protein synthesis
(SPPS). Here, organic chemistry is used to add amino acids
in a step-wise fashion. An advantage of SPPS is that one may
incorporate non-native amino acids with desired biophysical
properties. For example, the spin label TOAC attaches with
remarkable rigidity and serves as an outstanding reporter of
backbone £exibility and local structure [8^11].
Despite the great success enjoyed by these approaches, each
possesses limitations. For example, SDSL usually requires a
protein sequence free of native Cys residues so that only the
chosen location is labeled. In addition, the disul¢de bond in
the modi¢ed Cys side chain is labile and does not stand up to
temperatures greater than 60‡C [12] or extremes in pH. With
regard to TOAC labeling, the bulky nitroxide side chain hin-
ders conventional SPPS chemistry and often leads to low cou-
pling yields [13]. In addition, TOAC is a dialkyl side chain,
similar to K-isobutyric acid, and greatly favors helical torsion
angles [10]. Thus, TOAC is not readily incorporated into ex-
tended strands or L-sheets.
SPPS has advanced signi¢cantly in recent years and, with
exciting new technologies such as native chemical ligation
[14,15], one may now prepare high molecular weight proteins
solely by chemical means. Here we present a new approach
using SPPS for incorporating nitroxide side chains into pro-
teins. The strategy uses orthogonally protected amines within
a single amino acid for individual control of backbone and
side chain elongation. This approach has been explored else-
where for enhancing diversity in bioactive peptide libraries
[16,17]. In our application here, the focus is on incorporation
of biophysical probes. Although the method is general for
attaching a spin label to any amine-bearing side chain, we
demonstrate the approach using diaminopropionic (Dap)
acid as the sca¡old for nitroxide attachment. The result is a
peptide containing an enantiomerically pure amino acid pos-
sessing a side chain that links to its nitroxide through an
amide bond. We refer to this amino acid as Dap-SL. A series
of helical peptides containing one or two Dap-SL residues, in
conjunction with circular dichroism (CD) and nuclear mag-
netic resonance (NMR), are used to examine the side chain’s
in£uence on peptide conformation. EPR spectra are examined
to assess side chain mobility and, in a double label experi-
ment, sensitivity to local structure.
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2. Materials and methods
2.1. Peptide synthesis and puri¢cation
The peptide sequences were synthesized using standard Boc/Bzl
solid-phase peptide synthesis methods. The Dap sca¡old to which
the spin label was attached, NK-Boc-NL-Fmoc-L-2,3-diaminopropionic
acid, was purchased from Peptides International. The spin label was
attached to the resin-bound peptide using Fmoc peptide methodology
(20% piperidine deprotection), followed by coupling the HOAt/DIC-
activated carboxylic acid. Resin cleavage and removal of the side
chain protecting groups was achieved by treatment with anhydrous
HF with 10% p-cresol as scavenger at 0‡C for 1 h, followed by cold
diethyl ether precipitation and ¢ltration. The solid material was dis-
solved in aqueous solvent and promptly lyophilized. Puri¢cation of
the peptides was done using reversed-phase HPLC (pH 2.0^2.5 doubly
deionized water with 6 mM NaOH and 0.1% tri£uoroacetic acid
(TFA)=A; acetonitrile with 0.1% TFA=B), using C18 analytical
and semi-preparative columns. Puri¢ed material was lyophilized for
future use.
2.2. CD and electron spin resonance
All aqueous samples were bu¡ered to pH 7.0 in MOPS. CD spectra
were acquired on an Aviv 60DS spectropolarimeter, with temperature
regulation provided by a circulating water/ethylene glycol bath at-
tached to the cuvette holder. The CD spectrometer was calibrated
using the (+)-10-camphorsulfonic acid standard. For CD measure-
ments, samples contained usually 100 WM peptide in a ¢nal volume
of 200 Wl. EPR signal integration was used to determine peptide con-
centrations for quantitative CD measurements [12]. All spin concen-
trations were made relative to a stock solution of TEMPOL in MOPS
bu¡er at pH 7.0 that had been made precisely to 2.00 mM concen-
tration as determined by UV-Vis absorption. The CD samples were
acquired at 1.0‡C, with sample in a 0.1 cm path length quartz cuvette.
All EPR spectra were recorded on a Bruker ESP 380 spectrometer,
using methods described previously [12,18]. The temperature was con-
trolled using a Bruker variable temperature unit with liquid nitrogen
as the coolant.
2.3. NMR
Methods for determining two-dimensional NMR spectra of spin-
labeled peptides have been described previously [19]. Brie£y, all NMR
spectra were recorded on a Varian Unity+ 500 MHz spectrometer.
Peptide concentrations were all approximately 2 mM and determined
by the same method as used for the CD samples. The spins of each
sample were subsequently reduced using ascorbic acid. The solution
containing the reduced peptide was lyophilized, reconstituted in 90/10
H2O/D2O and brought to pH 5.0 for acquisition of NOESY and
TOCSY 1H two-dimensional homonuclear spectra. The NOESY spec-
tra were typically acquired with a 400 ms mixing time and 700 incre-
ments in the t1 dimension, whereas the TOCSY spectra were acquired
with a 50 ms mixing time and 350^512 increments. Spectra were
acquired at 2‡C, with temperature controlled by passing dry nitrogen
gas through a coil immersed in 6350‡C neat isopropanol. Data were
processed using nmrPipe [20] and visualized using NMRView (Bruce
A. Johnson, Merck Research Laboratories). All spectra were zero-
Fig. 1. Synthetic scheme showing how the Dap-SL is incorporated using the orthogonally protected Boc-Dap(Fmoc)-OH sca¡old. (Xaa)n and
(Xaa)m refer to the n and m amino acids preceding and following the Dap-SL, respectively. This scheme allows for incorporation of di¡erent
enantiomerically pure sca¡olds, as well as di¡erent carboxyl-containing nitroxides, for wide-ranging variation of the spin label side chain.
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¢lled to 1024U2048 complex points prior to Fourier transformation.
CSIs were tabulated according to the methods of Wishart et al. [21].
3. Results
The synthetic scheme for incorporating Dap-SL into a pep-
tide is shown in Fig. 1. The two amines in Dap are protected
using Boc and Fmoc groups that cleave in the presence of acid
and base, respectively. Standard Boc chemistry from the resin-
attached C-terminal amino acid is used to prepare the peptide
sequence. Protected Dap is incorporated at the appropriate
position and the Fmoc group remains attached throughout
peptide synthesis. When the peptide sequence is complete,
but still on the resin, the Fmoc group is removed with base.
The carboxylic acid on the nitroxide, activated by a coupling
agent, then couples to the unprotected amine. Side chain de-
protection and cleavage from the resin in acid produces the
¢nal peptide containing the Dap-SL amino acid.
The speci¢c scheme in Fig. 1 was designed to maintain the
integrity of the nitroxide group. Using Boc chemistry for
chain assembly insures that the only strong acid seen by the
nitroxide is HF in the ¢nal side chain deprotection and resin
cleavage step. Nitroxides are robust in HF and the only side
reaction is protonation of the NO group, which is readily
reversed with weak base. Alternatively, Fmoc chemistry relies
on TFA for the ¢nal protection group removal and resin
cleavage. Exposure to TFA can result in irreversible destruc-
tion of the nitroxide according to some protocols [13]. This
destruction is avoided with the scheme outlined here.
The 3K peptide Ac-AAAAKAAAAKAAAAKA-NH2 was
used as a host for exploring the synthetic and biophysical
properties of Dap-SL. The 3K sequence is partially helical
in aqueous solution and has been exploited in numerous stud-
ies for assessing helix stability and folding pathways [22^27].
We prepared the family of three labeled peptides shown below




Similar peptide series have been examined previously with
both Cys-SL [26,27] and TOAC labels [8,10]. Spin^spin inter-
actions in the 34,7 and 34,8 labeling scheme provide a probe
of peptide conformation. The singly labeled 3K(Dap)-8 serves
as a control by allowing measurement of the EPR spectrum in
the absence of spin^spin interactions.
With all three peptides, synthesis was straightforward, and
puri¢cation followed standard protocols. The Boc and Fmoc
couplings were e⁄cient and only trace side products were
identi¢ed by HPLC or mass spectrometry. Of note is that
the 3K sequence contains amines at each of the three Lys
residues, yet only the desired Dap amine was labeled.
CD was used to probe helix content in all peptides in pH 7
aqueous solution at 274 K; the spectra are shown in Fig. 2.
All three spectra exhibit minima at 208 nm and 222 nm char-
acteristic of polypeptide helices. Comparison of the spectra to
that from the original 3K peptide suggests a decrease in ap-
parent helix content. Estimates based on the mean residue
ellipticity at 222 nm for each peptide place the helix content
at V50% for 3K(Dap)-8 and 3K(Dap)-4,8, and 30% for
3K(Dap)-4,7 [28]. This is compared to the 80% helix for the
unmodi¢ed 3K sequence [23]. Thus, CD suggests that Dap-SL
is somewhat less helix-favoring than Ala. The peptides were
also examined in 1:1 (v/v) water/TFE at 274 K, which is a
standard solvent system for promoting helical structure. The
three resulting spectra are almost superimposable with nega-
tive minima exhibiting approximate equal intensity consistent
with a well-structured helix.
The nitroxide and amide bond in the Dap-SL side chain
both absorb in the CD active ultraviolet region and thus
may interfere with quantitative helix determinations using
the spectra in Fig. 2 [29]. In addition, the 3K(Dap)-4,7 ap-
pears to be less helical than the remaining peptides. To inves-
tigate further, we used NMR to assess relative structure in this
family of peptides. Chemical shifts, referenced against estab-
lished random coil values, are extremely sensitive to secondary
structure [21]. A conformational shift (experimental chemical
shift minus random coil chemical shift) of 30.1 ppm indicates
helix and a conformational shift of 0.1 ppm indicates
L-strand. We have shown previously that gentle ascorbic acid
reduction of the nitroxide to the hydroxylamine allows for
detailed NMR analysis of spin-labeled peptides without inter-
ference from the paramagnetic center [19]. Using two-dimen-
sional NOESY and TOCSY, the conformational shifts were
determined for all three peptides and the results are compared
to that of the original 3K sequence in Fig. 3. Consistent with
the ¢ndings from CD, all three Dap-SL peptides give strongly
Fig. 2. CD spectra of the family of Dap-SL-containing peptides in
(a) MOPS bu¡er pH 7.0 and (b) 1:1 (v/v) water/TFE. These spectra
demonstrate that the spin-labeled peptides adopt helical structure
similar to the unlabeled 3K; however, in aqueous solution alone the
helix content may be somewhat reduced.
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helical conformational shifts. In addition, to within experi-
mental error, the data in Fig. 3 suggest that all of the labeled
peptides possess nearly equivalent conformational shifts as the
original 3K sequence. Although the CD spectra suggest a
decrease in helix content relative to the 3K peptide, especially
for the 3K(Dap)-4,7, the NMR conformational shifts suggest
that there is little to no perturbation introduced by Dap-SL.
Fig. 4 shows EPR spectra obtained at 274 K from the
family of peptides. The 3K(Dap)-8 gives sharp lines consistent
with a singly labeled species. The rotational correlation, de-
termined using motional narrowing theory, is 0.20 ns [12]. A
homologous peptide labeled with MTSSL at position 8 gives a
correlation time of 0.45 ns [30] thereby suggesting that the
Dap-SL side chain is more £exible than the Cys-SL side chain.
Consistent with the introduction of a biradical interaction,
the doubly labeled peptides give substantially broader lines
than the singly labeled peptide. While the detailed line-broad-
ening mechanisms are not known, it is believed that they arise
from a combination of residual dipolar coupling, scalar J-cou-
pling and time-dependent modulation of these couplings lead-
ing to rapid relaxation [9,31]. Despite the speci¢c interaction,
the extent of line broadening correlates inversely with distance
between the labels. Inspection of the spectra obtained from
the aqueous samples suggests that the 3K(Dap)-4,7 and
3K(Dap)-4,8 line widths are nearly equivalent but with the
3K(Dap)-4,7 being slightly broader. Thus, the distances be-
tween the labels in each peptide are approximately equivalent.
A similar distance hierarchy was observed previously in ho-
mologous Cys-SL containing peptides and was interpreted as
arising from an admixture of 310-helix and K-helix. In a pure
K-helix, the 34,8 distance is shorter than the 34,7 and this is
indeed observed for longer helical peptides (see [26] for anal-
ysis). The doubly labeled peptides were also examined in the
helix-promoting solvent system water/TFE. Here the lines are
broader re£ecting either enhancement of the helical structure,
consistent with the CD spectra, or increased viscosity relative
to water. The relative line broadening still suggests an admix-
ture of 310-helix and K-helix.
The broad spectra obtained from the doubly labeled species
do not exhibit superimposed narrow line components as might
arise from contamination from a monoradical species. To test
the robustness of the Dap-SL side chain, aqueous samples of
the singly and doubly labeled species were brought to approx-
Fig. 3. K-Proton conformational shifts (chemical shift minus random coil chemical shifts) for the peptides in this study. The strongly negative
shifts are characteristic of helical structure. All peptides exhibit approximately the same position-dependent pattern suggesting that helix content
and structure is preserved in all labeled peptides.
Fig. 4. EPR spectra of Dap-SL-containing peptides. Analysis of the
singly labeled 3K(Dap)-8 spectrum yields a rotational correlation
time of 0.2 ns. The doubly labeled spectra exhibit broader lines con-
sistent with biradical interactions.
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imately 90‡C for several minutes. After the samples were
cooled, the EPR spectra were reacquired. There were no mea-
surable changes in any of the spectra indicating that the side
chains remained intact.
4. Discussion
We have developed a new approach for the site-speci¢c
placement of spin labels in chemically synthesized peptides
and proteins. The label was tested in a series of helical pep-
tides. Analysis of the CD and NMR data demonstrates that
the Dap-SL does not introduce a signi¢cant perturbation in
the helical structure. However, when considering the CD
alone, the Dap-SL side chain appears to be less helix-favoring
than Ala. EPR shows that the Dap-SL side chain is more
£exible than the widely used Cys-SL. However, EPR of the
doubly labeled peptides yielded results similar to that ob-
tained previously from peptides containing Cys-SL side chains
and demonstrates that double labeling with Dap-SL serves as
a useful probe of secondary structure.
The synthetic scheme in Fig. 1 was designed to provide a
convenient means for wide-ranging site-directed spin labeling
applications. In principle, one could prepare Fmoc or Boc
nitroxide amino acids and incorporate them directly through
normal peptide synthesis as demonstrated with TOAC. How-
ever, this approach involves synthesis of signi¢cant quantities
of the protected nitroxide amino acid since these reagents are
added in large (usually fourfold) excess to the peptide on the
resin. In addition, for chiral nitroxide amino acids, one must
have enantiomerically pure materials. Fig. 1 shows that in the
scheme here one may use commercially available reagents
along with any nitroxide containing a carboxyl group. In ad-
dition, by simply varying the orthogonally protected sca¡old,
one may readily develop a series of nitroxide side chains of
varying length, as has been demonstrated in peptide libraries
[17].
Dap-SL opens new avenues for preparation of spin-labeled
proteins. We consider two examples from our own laboratory.
We have recently determined the NMR structure of the agou-
ti-related protein (AGRP), a potent antagonist of a subfamily
of G protein-coupled receptors called melanocortin receptors
(MCRs) [32]. As technologies evolve for overexpression and
biophysical studies of MCRs, having spin-labeled AGRP
could be remarkably useful for evaluating receptor binding
domains and conformational changes. AGRP contains
10 Cys residues essential for activity and is thus not amenable
to MTSSL labeling. In addition, it contains no helical struc-
ture and will likely be perturbed by incorporation of TOAC.
However, AGRP can be prepared by SPPS [33] and is thus
conveniently labeled with the Dap-SL scheme described here.
Another research direction involves the copper binding sites
in the octarepeat domain of the prion protein. We have re-
cently used peptide design, EPR and isotopic labeling to de-
termine the molecular features of these metal ion binding sites
[34,35]. At this juncture, however, there is little information
regarding how these sites organize relative to each other in the
full copper binding domain. Spin label technologies could be
ideal for determining local motions and organization. Cys-SL
labeling is probably not feasible since thiols bind avidly to
copper; TOAC labeling is also problematic since there are
no helical stretches for incorporation. However, Dap-SL
should not interfere with either normal copper binding or
native backbone structure and thus may be key for addressing
issues of organization in the holo protein. In conclusion, Dap-
SL promises to open many new avenues of spin label research.
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